Dr. Darshan Patel is a dual board-certified physician in Internal Medicine and Obesity Medicine with extensive clinical and administrative experience and a passion for delivering patient-centered care. He began medical school at the age of 17, earning his MBBS from Gujarat University, India. He completed his residency in Internal Medicine at the Icahn School of Medicine at Mount Sinai and further honed his expertise by completing the Blackburn Course in Obesity Medicine at Harvard Medical School.
With over a decade of experience, Dr. Patel has served as an attending physician and medical director, improving healthcare delivery by implementing innovative technologies, optimizing workflows, and enhancing patient care systems. He has been a leader in quality improvement and behavioral health initiatives.
As the founder of Aayu Well Healthcare, Dr. Patel specializes in obesity management and weight loss. He has been practicing obesity medicine for several years and has experience prescribing GLP-1 medications, including Ozempic, since its launch. His clinical approach integrates advanced therapies with lifestyle modifications to help patients achieve sustainable health outcomes.
See More
See Less
Board Certifications
Obesity Medicine
Internal Medicine
Education
Medical Education: MBBS [09/2005 – 09/2011] Gujarat University, Gujarat, India.
Masters in Clinical Research: [09/2014 – 09/2020]Rush University, Chicago, IL.
MBA: evening program. Received a merit-based scholarship. [09/2022 –current] The University of Chicago Booth School of Business, Chicago, IL.
Postdoctoral Training
Resident at Internal Medicine: [07/2015 – 06/2018] Icahn School of Medicine at Mount Sinai (Elmhurst), NY.
Blackburn Course in Obesity Medicine: [06/2024] Harvard Medical School, MA.
Publications
Cardiac Amyloidosis: Pathogenesis, Clinical Context, Diagnosis and Management Options-- Acta Cardiologica. Published 07/2017
Utilization of routine labs to determine length of stay, mortality and readmission rates for patients admitted with acute heart failure syndrome—–Poster Presentation—CSCTR, Chicago 2018
Worsening Blood Urea Nitrogen and Creatinine Predicts30-Day Readmission Rate and Length of Stay Among Patients with Heart Failure and Reduced Ejection Fraction Admitted for Acute Heart Failure Syndrome. –Poster Presentation –HFSA 2017.
Trends of Hospitalization in US between2000-2012 of patients >60 years of age with aortic valve disease – The American Journal of Cardiology. Published 07/2015.
Liver Functions Tests (LFT) Predicting Mortality in Heart Failure Patients. –Poster Presentation—ACG 2016
Impact of Median Household Income and Hospitals Variation in The Utilization of Do-Not-Resuscitate Order in Cardia Arrest: A National Perspective. – Poster Presentation – Poster Presentation –AHA2014.
Disclosures
NONE
State Medical Licenses
Illinois, Ohio, Michigan, Indiana, Wisconsin , California, Georgia
Contact & Locations
Aayu Well
230 E Ohio St Suite 410 2291
Chicago IL 60611 United States
